Point-of-care testing hub

What is point-of-care testing (POCT)?

Point-of-care testing (POCT), also known as near-patient testing (NPT), are tests performed outside the laboratory – usually at the bedside or in wards. POCT can produce test results within minutes and are generally portable. Technology improvements, a growing need to expand access to testing for diverse test settings and users, are driving a decentralisation trend in in vitro diagnostics (IVD) testing. Clearstate offers market data, forecasts, and trend predictions to give you the insight to adjust your business strategy to the increasing demand for affordable POC tests.

POCT updates

Our POCT hub is regularly updated to share our findings on this fast-growing diagnostic alternative. Explore the latest in POCT technology and applications as affordable solutions are developed and adopted in the market. Understand the implications of the emergence of POCT alternatives to laboratory testing, and examine the issues that arise from growing competition in this segment of the market. Discover more IVD insights or learn how our IVD Gateway solution can help prepare your business for the future impact of the emergence of POCT.

Explore how Clearstate can enable your business to stay ahead in the market, enquire now.

Explore the latest POCT market insights

From market news to analysis, our articles provide concise and up-to-date information about the developments driving testing closer to patients. Uncover the challenges and opportunities countries face to increase diagnostic coverage, disease monitoring and patient outcomes for the population through POCT.

Learn from leading experts and analysts, and see real-world examples on how IVD testing is decentralising.

APAC IVD companies to watch in the infectious diseases diagnostics market

Covid-19: point-of-care vs. lab-based testing

Covid-19 testing has emerged as a top priority for clinical laboratories and many IVD players. SARS-CoV-2 tests make up more than half of Asia-Pacific’s (APAC’s) total infectious disease diagnostics market.

Winning market share in the rise of connected blood glucose testing at Chinese hospitals

In China, the use of connected point-of-care (POC) blood glucose testing will play an increasingly important role in diabetes management at hospitals. China has the largest number of diabetes cases in the world. Besides patients hospitalised for diabetes complications, the country also has a large population of inpatients with high blood glucose levels which has been associated with increased hospitalisation expenses.

Point-of-Care Infectious Diseases Testing in Developing Countries infographic

3 Test Areas to Watch in Point-of-Care Infectious Diseases Testing in Developing Countries

In this infographic, EIU Healthcare picks out high-growth test areas in infectious diseases to watch based on data and forecasts from IVD Gateway, shedding light on where and how companies can help expand access to POC testing in developing countries.

The Future of Point-of-Care (POC) Testing in Asia-Pacific (APAC)

Point-of-care (POC) diagnostics is expected to be one of the fastest-growing major in-vitro diagnostics (IVD) market segments in Asia-Pacific (APAC). EIU Healthcare estimates the APAC POC diagnostics market to increase by 6.4% annually on average during the 2019-2024 forecast period.

The future of point-of-care testing in Latin America

As Latin America (LATAM) experiences a shift towards decentralised IVD testing and greater constraints on fiscal budgets and healthcare systems, IVD companies will have to adapt their market strategy to meet the region’s increased demand for affordable point-of-care (POC) tests, particularly around infectious diseases. EIU Healthcare estimates the POC diagnostics market to grow by 5.6% annually on average during the 2019-2024 forecast period.

Understand the POCT market

In order to determine the future outlook of the POCT market, we must first understand and integrate macro insights on population trends, epidemiology, reimbursement, local affordability levels, testing landscape. Our reports show how and where businesses can capture opportunities in the decentralisation trend in testing unfolding across countries, and key customer segments across a wide range of applications.

report by clearstate

The Future of Point-of-care Testing in Latin America

The report explores how the region is tackling infectious disease impact through decentralised diagnostics.

Learn more